BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26535637)

  • 1. Association of the IL6 polymorphism rs1800796 with cancer risk: a meta-analysis.
    Du Y; Gao L; Zhang K; Wang J
    Genet Mol Res; 2015 Oct; 14(4):13236-46. PubMed ID: 26535637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
    Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
    Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the interleukin-6-174 G/C polymorphism and risk of ischemic stroke: a meta-analysis.
    Jin XF; Wang DL; Zhou Y; Xiong H
    Genet Mol Res; 2015 Oct; 14(4):13076-83. PubMed ID: 26535620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between IL6 polymorphism and risk of cerebral infarction.
    Han YH
    Genet Mol Res; 2015 Dec; 14(4):16438-43. PubMed ID: 26662441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
    Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
    Chen CH; Gong M; Yi QT; Guo JH
    Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.
    Zhai K; Yang Y; Gao ZG; Ding J
    Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the -607 C > A polymorphism in interleukin-18 gene promoter with gastrointestinal cancer risk: a meta-analysis.
    Yao J; Li ZH; Li YX; Zhang R; Zhang DG; Xu ZL; Wang LS; Wang JY
    Genet Mol Res; 2015 Dec; 14(4):16880-7. PubMed ID: 26681034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.
    Huang WJ; Wu LJ; Min ZC; Xu LT; Guo CM; Chen ZP; Lou XJ; Xu B; Lv BD
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis.
    Mao X; Ke Z; Liu S; Tang B; Wang J; Huang H; Chen S
    Gene; 2015 Nov; 573(1):75-83. PubMed ID: 26169021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between IL-6 -174G>C polymorphism and lung cancer: a meta-analysis.
    Liu Y; Song XL; Zhang GL; Peng AM; Fu PF; Li P; Tan M; Li X; Li M; Wang CH
    Genet Mol Res; 2015 Jan; 14(1):163-9. PubMed ID: 25729947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of the IL-6 gene 634C/G polymorphism with susceptibility to endometriosis].
    Mao T; Zong LL; Wang YF; Zhao X; Fu YG; Zeng J; Rao XQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Oct; 28(5):555-8. PubMed ID: 21983734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between polymorphisms in -572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: A meta-analysis.
    Zhang C; Jiao S; Li T; Zhao L; Chen H
    Int J Rheum Dis; 2020 Jan; 23(1):47-54. PubMed ID: 31782615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of the tumor necrosis factor-alpha -1031T/C and its combination with interleukin-6 -634C/G gene polymorphisms with susceptibility to endometriosis].
    Mao T; Zong LL; Wang YF; Zeng J; Fu YG; Zhao X; Rao XQ; Huang YX; Xu ZM; Zhu XN
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):328-32. PubMed ID: 22883518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.
    Zakharyan R; Petrek M; Arakelyan A; Mrazek F; Atshemyan S; Boyajyan A
    Tissue Antigens; 2012 Aug; 80(2):136-42. PubMed ID: 22571276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.
    Zhang S; Gao X; Yang J; Ji Z
    J Cancer Res Ther; 2015; 11(2):308-12. PubMed ID: 26148591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis.
    Konwar C; Del Gobbo GF; Terry J; Robinson WP
    BMC Med Genet; 2019 Feb; 20(1):36. PubMed ID: 30795743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter Polymorphism (-174, G/C) of Interleukin-6 and Arterial Thromboembolic Events: A Meta-Analysis.
    Kim SK; Chung JH; Kwon OY
    Med Sci Monit; 2016 Nov; 22():4345-4353. PubMed ID: 27840402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-6 rs1800795 and rs1800796 polymorphisms are associated with coronary artery disease risk.
    Lu S; Wang Y; Wang Y; Hu J; Di W; Liu S; Zeng X; Yu G; Wang Y; Wang Z
    J Cell Mol Med; 2020 Jun; 24(11):6191-6207. PubMed ID: 32374489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
    Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
    Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.